Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants
Guardado en:
Autores principales: | Yi-Jiao Huang, Hui Zhao, Xun Huang, Yong-Qiang Deng, Xiao-Feng Li, Qing Ye, Rui-Ting Li, Yan-Peng Xu, Tian-Shu Cao, Cheng-Feng Qin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0b5891a9917469cb2dc4c8810542461 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Lin Cheng, et al.
Publicado: (2021) -
Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha)
por: Shuai Xia, et al.
Publicado: (2021) -
Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01
por: Shiyu Sun, et al.
Publicado: (2021) -
Establishment of human distal lung organoids for SARS-CoV-2 infection
por: Ting Wang, et al.
Publicado: (2021) -
Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV
por: Shilin Yuan, et al.
Publicado: (2021)